RecruitingNCT04579588

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Sponsor

Stanford University

Enrollment

230 participants

Start Date

Oct 29, 2020

Study Type

OBSERVATIONAL

Conditions

Immunity Corona Virus Infection Flu Vaccine

Summary

The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 9 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Eligibility

Min Age: 9 YearsMax Age: 64 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Flu shot for people with corona virus infection, flu vaccine, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 9 Years to 64 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.